IL6 and liver cancer: For instance, high BMI boosts Interleukin-6 and tumor necrosis factor production, triggering hepatic inflammation and activating the oncogenic transcription factor STAT3 (signal transducer and activator of transcription 3), thereby driving liver cancer progression (51).